TB-500 is a 43-residue, 4963.4 g/mol thymosin beta 4 sequence acting through G-actin sequestration and integrin-linked kinase signalling, studied mainly in cardiac, corneal, dermal and skeletal muscle models
A 2025 meta-analysis of 16 studies involving 6,098 participants found no statistically significant difference between intramuscular, oral, and sublingual B12 supplementation routes (p=0.270)
It is in Phase 3 investigational trials as a "next generation" weight loss medication with potentially fewer side effects compared to single-receptor predecessors like Semaglutide or dual receptor meds like Tirzepatide
CJC-1295 and Ipamorelin stimulate the body natural growth hormone release, which enhances tissue repair, muscle recovery, and fat metabolism
In 1997, Sikiri's own lab reported that BPC-157 did something in the brain it blunted the effects of amphetamine, blocking "the stereotypy produced acutely by amphetamine" [10]
Focus & Clarity: Improves mental sharpness and cognitive function